20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165)

NCT01568229 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
111
Enrollment
INDUSTRY
Sponsor class

Stopped Toxic Epidermal Necrolysis

Conditions

Interventions

Sponsor

Amgen